✦ LIBER ✦

Prognostic Impact of Histopathologic Response after Neoadjuvant Chemotherapy in Stage IIIANon-small Cell Lung Cancer

✍ Scribed by Jian LI; Jiannong WU; Hao QIU; Lichao YU; Dehou ZHANG; Shunbin SHI; Ming DING

Publisher: Springer
Year: 2006
Tongue: English
Weight: 161 KB
Volume: 5
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-005-0424-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of Surgical Treatment After Neoa

Results of Surgical Treatment After Neoadjuvant Chemotherapy for Stage III Non-Small Cell Lung Cancer

✍ Angelo Carretta; Paola Ciriaco; Giulio Melloni; Imad Sayed; Alessandro Bandiera; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 215 KB

18F-FDG PET for assessment of therapy re

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

✍ Susanne Martina Eschmann; Godehard Friedel; Frank Paulsen; Matthias Reimold; Tho 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 206 KB

Trimodality treatment in Stage III nonsm

Trimodality treatment in Stage III nonsmall cell lung carcinoma : Prognostic impact of K-ras mutations after neoadjuvant therapy

✍ Petra Broermann; Klaus Junker; Burkhard H. Brandt; Achim Heinecke; Lutz Freitag; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Prognostic impact of nm23-H1 and PCNA ex

Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer

✍ Chengying Liu; Jun Liu; Xin Wang; Weidong Mao; Lian Jiang; Hua Ni; Mingcong Mo; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## Abstract ## Introduction The purpose of this study was to evaluate the value of nm23‐H1 and proliferating cell nuclear antigen (PCNA) expression as well as other confirmed prognostic factors in predicting the clinical outcome after definitive surgery of pathologic stage I non‐small cell lung ca

Prognostic impact of MMP-2 and MMP-9 exp

Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer

✍ Wenlong Shao; Wei Wang; Xin-guo Xiong; Christopher Cao; Tristan D. Yan; Guoqin C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

## Abstract ## Background The purpose of the present study was to assess the value of matrix metalloproteinase (MMP)‐2 and MMP‐9 expression and other potential prognostic factors in predicting the clinical outcome of patients after definitive surgery for pathologic stage IA non‐small cell lung can

Phase II study of neoadjuvant chemothera

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

✍ Margaret Deutsch; Jeffrey Crawford; Kenneth Leopold; Walter Wolfe; William Foste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB